Objective： To investigate the adjuvant therapeutic effects of fermented red ginseng（FRG） extract on non-small cell lung cancer（NSCLC） patients treated with chemotherapy. Methods： A total of 60 patients with adva...Objective： To investigate the adjuvant therapeutic effects of fermented red ginseng（FRG） extract on non-small cell lung cancer（NSCLC） patients treated with chemotherapy. Methods： A total of 60 patients with advanced NSCLC were assigned to two groups using a random number table, i.e., the gemcitabine plus cisplatin（GP） chemotherapy alone group（26 patients） and the FRG ＋ GP chemotherapy group（34 patients）, for 60-day treatment. Patients were then assessed according to the Fatigue Symptom Inventory, Chinese medicine symptoms score, Self-Rating Anxiety Scale, Self-Rating Depression Scale, Karnofsky Performance Status Scale, and Functional Assessment of Cancer Therapy-Lung. In addition, chemotherapy toxicity and tumor biomarkers were measured. Results： For NSCLC patients after chemotherapy, FRG extract significantly improved the FSI score, CM symptoms score, psychological status, physical conditions, and quality of life and reduced chemotherapy toxicity（P〈0.01）, but the expression levels of carcinoembryonic antigen, cytokeratin-19 fragments, and neuron-specific enolase were not significantly different between the chemotherapy alone and the FRG ＋ chemotherapy groups or between pre-and post-treatments（P〉0.05）. Conclusions： This study demonstrated that FRG extract had an adjuvant effect on advanced NSCLC patients treated with chemotherapy. Further studies with a larger sample size will verify the current findings.展开更多
红参为珍贵的药材,已有1000多年的历史,遍及中国、韩国、日本等亚洲国家。韩国红参(korean red ginseng,KRG)不仅是滋补品,也是用于治疗免疫疾病、肝病、癌症等疾病的传统药材。KRG含有多种人参皂苷、糖类、微量元素等成分,具有较高的...红参为珍贵的药材,已有1000多年的历史,遍及中国、韩国、日本等亚洲国家。韩国红参(korean red ginseng,KRG)不仅是滋补品,也是用于治疗免疫疾病、肝病、癌症等疾病的传统药材。KRG含有多种人参皂苷、糖类、微量元素等成分,具有较高的药用价值,韩国各机构对其进行了较深入的研究,近5年在美国《科学引文索引》上发表文章数百篇。目前实验研究主要集中在红参有效成分的筛选及其药理作用,临床研究以单方制剂为主。笔者通过查阅KRG相关文献,从增强免疫、抗疲劳、抗衰老、抗氧化、调节糖脂代谢、抗炎、抗肿瘤以及在多个系统疾病中的运用等多方面对其药理作用进行了概述,为KRG的进一步研究与临床应用提供依据。展开更多
目的:探讨高丽参提取液(Korean red ginseng extract,KRG)对实验性自身免疫性脑脊髓膜炎(EAE)的治疗作用及相关免疫调节机制。方法:取SD大鼠30只,随机分为空白对照组、模型组(实验性自身免疫性脑脊髓炎模型)和实验组(高丽参提取液治疗)...目的:探讨高丽参提取液(Korean red ginseng extract,KRG)对实验性自身免疫性脑脊髓膜炎(EAE)的治疗作用及相关免疫调节机制。方法:取SD大鼠30只,随机分为空白对照组、模型组(实验性自身免疫性脑脊髓炎模型)和实验组(高丽参提取液治疗),每组10只,对EAE大鼠进行神经功能评分及体重测量,通过病理学HE染色和免疫组化观察25 d脑和脊髓炎症浸润,流式细胞术检测大鼠脊髓和淋巴结CD4^+、CD4^+/IFN-γ^+(Th1)、CD4^+/IL-17^+(Th17)和CD4^+/Foxp3^+T细胞数量,实时荧光定量q-PCR检测大鼠脊髓和淋巴结IFN-γ、IL-17、IL-23和Foxp3 m RNA水平的表达。结果:治疗组大鼠神经功能评分明显改善,体重明显增加;与模型组比较,实验组神经症状和病理改变减轻;与模型组相比,治疗组中大鼠脊髓和淋巴结CD4^+、CD4^+/IFN-γ^+、CD4^+/IL-17^+T细胞数量减少,而CD4^+/Foxp3^+T细胞数量增多(P<0.05);大鼠脊髓和淋巴结IFN-γ、IL-17、IL-23 m RNA表达下降,而Foxp3 m RNA表达增加(P<0.05)。结论:高丽参提取液通过调节免疫系统的CD4^+、CD4^+/IFN-γ^+、CD4^+/IL-17^+和CD4^+/Foxp3^+T细胞数量和CD4~^+T细胞分泌细胞因子的水平对EAE起保护作用。展开更多
基金Supported in part by a grant from the Major Projects for"Creation of Major New Drugs"of the Ministry of Science and Technology of China(No.2010ZX09102-216)the Korea Joongbu University Research Fund
文摘Objective： To investigate the adjuvant therapeutic effects of fermented red ginseng（FRG） extract on non-small cell lung cancer（NSCLC） patients treated with chemotherapy. Methods： A total of 60 patients with advanced NSCLC were assigned to two groups using a random number table, i.e., the gemcitabine plus cisplatin（GP） chemotherapy alone group（26 patients） and the FRG ＋ GP chemotherapy group（34 patients）, for 60-day treatment. Patients were then assessed according to the Fatigue Symptom Inventory, Chinese medicine symptoms score, Self-Rating Anxiety Scale, Self-Rating Depression Scale, Karnofsky Performance Status Scale, and Functional Assessment of Cancer Therapy-Lung. In addition, chemotherapy toxicity and tumor biomarkers were measured. Results： For NSCLC patients after chemotherapy, FRG extract significantly improved the FSI score, CM symptoms score, psychological status, physical conditions, and quality of life and reduced chemotherapy toxicity（P〈0.01）, but the expression levels of carcinoembryonic antigen, cytokeratin-19 fragments, and neuron-specific enolase were not significantly different between the chemotherapy alone and the FRG ＋ chemotherapy groups or between pre-and post-treatments（P〉0.05）. Conclusions： This study demonstrated that FRG extract had an adjuvant effect on advanced NSCLC patients treated with chemotherapy. Further studies with a larger sample size will verify the current findings.
文摘红参为珍贵的药材,已有1000多年的历史,遍及中国、韩国、日本等亚洲国家。韩国红参(korean red ginseng,KRG)不仅是滋补品,也是用于治疗免疫疾病、肝病、癌症等疾病的传统药材。KRG含有多种人参皂苷、糖类、微量元素等成分,具有较高的药用价值,韩国各机构对其进行了较深入的研究,近5年在美国《科学引文索引》上发表文章数百篇。目前实验研究主要集中在红参有效成分的筛选及其药理作用,临床研究以单方制剂为主。笔者通过查阅KRG相关文献,从增强免疫、抗疲劳、抗衰老、抗氧化、调节糖脂代谢、抗炎、抗肿瘤以及在多个系统疾病中的运用等多方面对其药理作用进行了概述,为KRG的进一步研究与临床应用提供依据。
文摘目的:探讨高丽参提取液(Korean red ginseng extract,KRG)对实验性自身免疫性脑脊髓膜炎(EAE)的治疗作用及相关免疫调节机制。方法:取SD大鼠30只,随机分为空白对照组、模型组(实验性自身免疫性脑脊髓炎模型)和实验组(高丽参提取液治疗),每组10只,对EAE大鼠进行神经功能评分及体重测量,通过病理学HE染色和免疫组化观察25 d脑和脊髓炎症浸润,流式细胞术检测大鼠脊髓和淋巴结CD4^+、CD4^+/IFN-γ^+(Th1)、CD4^+/IL-17^+(Th17)和CD4^+/Foxp3^+T细胞数量,实时荧光定量q-PCR检测大鼠脊髓和淋巴结IFN-γ、IL-17、IL-23和Foxp3 m RNA水平的表达。结果:治疗组大鼠神经功能评分明显改善,体重明显增加;与模型组比较,实验组神经症状和病理改变减轻;与模型组相比,治疗组中大鼠脊髓和淋巴结CD4^+、CD4^+/IFN-γ^+、CD4^+/IL-17^+T细胞数量减少,而CD4^+/Foxp3^+T细胞数量增多(P<0.05);大鼠脊髓和淋巴结IFN-γ、IL-17、IL-23 m RNA表达下降,而Foxp3 m RNA表达增加(P<0.05)。结论:高丽参提取液通过调节免疫系统的CD4^+、CD4^+/IFN-γ^+、CD4^+/IL-17^+和CD4^+/Foxp3^+T细胞数量和CD4~^+T细胞分泌细胞因子的水平对EAE起保护作用。
